{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:26:32Z","timestamp":1790400392779,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/ijo.2017.126","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T07:40:37Z","timestamp":1495784437000},"page":"1331-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity"],"prefix":"10.1038","volume":"41","author":[{"given":"A","family":"Couto Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Valcarcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V-P","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Morin-Papunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Kangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Soininen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"De Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Coin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ala-Korpela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-R","family":"J\u00e4rvelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"BFijo2017126_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S . Polycystic ovary syndrome. N Engl J Med 1995; 333: 853\u2013861.","journal-title":"N Engl J Med"},{"key":"BFijo2017126_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/humrep\/deh214","volume":"19","author":"S Taponen","year":"2004","unstructured":"Taponen S, Ahonkallio S, Martikainen H, Koivunen R, Ruokonen A, Sovio U et al. Prevalence of polycystic ovaries in women with self reported symptoms of oligomenorrhoea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod 2004; 19: 1083\u20131088.","journal-title":"Hum Reprod"},{"key":"BFijo2017126_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/jc.2002-020982","volume":"88","author":"S Taponen","year":"2003","unstructured":"Taponen S, Martikainen H, J\u00e4rvelin M-R, Laitinen J, Pouta A, Hartikainen A-L et al. Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 2003; 88: 141\u2013147.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1210\/jc.2003-031720","volume":"89","author":"S Taponen","year":"2004","unstructured":"Taponen S, Martikainen H, J\u00e4rvelin M-R, Sovio U, Laitinen J, Pouta A et al. Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 2004; 89: 2114\u20132118.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","volume":"66","author":"TM Barber","year":"2007","unstructured":"Barber TM, Wass JAH, McCarthy MI, Franks S . Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol 2007; 66: 513\u2013517.","journal-title":"Clin Endocrinol"},{"key":"BFijo2017126_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","volume":"65","author":"TM Barber","year":"2006","unstructured":"Barber TM, McCarthy MI, Wass JAH, Franks S . Obesity and polycystic ovary syndrome. Clin Endocrinol 2006; 65: 137\u2013145.","journal-title":"Clin Endocrinol"},{"key":"BFijo2017126_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE . Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 1929\u20131935.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/CCLM.2008.006","volume":"46","author":"M Ala-Korpela","year":"2008","unstructured":"Ala-Korpela M . Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clin Chem Lab Med 2008; 46: 27\u201342.","journal-title":"Clin Chem Lab Med"},{"key":"BFijo2017126_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jacc.2008.03.043","volume":"52","author":"GD Lewis","year":"2008","unstructured":"Lewis GD, Asnani A, Gerszten RE . Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 2008; 52: 117\u2013123.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2017126_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes E, Wilson ID, Nicholson JK . Metabolic phenotyping in health and disease. Cell 2008; 134: 714\u2013717.","journal-title":"Cell"},{"key":"BFijo2017126_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/gm335","volume":"4","author":"M Ala-Korpela","year":"2012","unstructured":"Ala-Korpela M, Kangas AJ, Soininen P . Quantitative high-throughput metabolomics: a new era in epidemiology and genetics. Genome Med 2012; 4: 36.","journal-title":"Genome Med"},{"key":"BFijo2017126_CR12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11306-012-0422-8","volume":"8","author":"AC Alves","year":"2012","unstructured":"Alves AC, Li JV, Garcia-Perez I, Sands C, Barbas C, Holmes E et al. Characterization of data analysis methods for information recovery from metabolic 1 H NMR spectra using artificial complex mixtures. Metabolomics 2012; 8: 1170\u20131180.","journal-title":"Metabolomics"},{"key":"BFijo2017126_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2013.12.018","volume":"429","author":"M Murri","year":"2014","unstructured":"Murri M, Insenser M, Escobar-Morreale HF . Metabolomics in polycystic ovary syndrome. Clin Chim Acta 2014; 429: 181\u2013188.","journal-title":"Clin Chim Acta"},{"key":"BFijo2017126_CR14","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011; 121: 1402\u20131411.","journal-title":"J Clin Invest"},{"key":"BFijo2017126_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17: 448\u2013453.","journal-title":"Nat Med"},{"key":"BFijo2017126_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","volume":"3","author":"SH Shah","year":"2010","unstructured":"Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, Haynes C et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 2010; 3: 207\u2013214.","journal-title":"Circ Cardiovasc Genet"},{"key":"BFijo2017126_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","volume":"126","author":"SH Shah","year":"2012","unstructured":"Shah SH, Kraus WE, Newgard CB . Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 2012; 126: 1110\u20131120.","journal-title":"Circulation"},{"key":"BFijo2017126_CR18","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.2337\/db11-1355","volume":"61","author":"P Wurtz","year":"2012","unstructured":"Wurtz P, Makinen VP, Soininen P, Kangas AJ, Tukiainen T, Kettunen J et al. Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 2012; 61: 1372\u20131380.","journal-title":"Diabetes"},{"key":"BFijo2017126_CR19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1039\/b910205a","volume":"134","author":"P Soininen","year":"2009","unstructured":"Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009; 134: 1781\u20131785.","journal-title":"Analyst"},{"key":"BFijo2017126_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/msb.2010.93","volume":"6","author":"M Inouye","year":"2010","unstructured":"Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol 2010; 6: 441.","journal-title":"Mol Syst Biol"},{"key":"BFijo2017126_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.1073","volume":"44","author":"J Kettunen","year":"2012","unstructured":"Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, Lyytikainen LP et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012; 44: 269\u2013276.","journal-title":"Nat Genet"},{"key":"BFijo2017126_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/jc.2002-020982","volume":"88","author":"S Taponen","year":"2003","unstructured":"Taponen S, Martikainen H, J\u00e4rvelin M-R, Laitinen J, Pouta A, Hartikainen A-L et al. Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab 2003; 88: 141\u2013147.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR23","first-page":"377","volume-title":"Polycystic Ovary Syndrome. edn","author":"J Zawadzki","year":"1992","unstructured":"Zawadzki J, Dunaif A . Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Merriam G. (eds). Polycystic Ovary Syndrome. edn. Blackwell Scientific: Boston, 1992; 377\u2013384."},{"key":"BFijo2017126_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2265.2000.01123.x","volume":"53","author":"E Kousta","year":"2000","unstructured":"Kousta E, Cela E, Lawrence N, Penny A, Millauer B, White D et al. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol 2000; 53: 501\u2013507.","journal-title":"Clin Endocrinol"},{"key":"BFijo2017126_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ajkd.2011.02.390","volume":"58","author":"H Kramer","year":"2011","unstructured":"Kramer H, Shoham D, McClure LA, Durazo-Arvizu R, Howard G, Judd S et al. Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 2011; 58: 177\u2013185.","journal-title":"Am J Kidney Dis"},{"key":"BFijo2017126_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","volume":"95","author":"J Li","year":"2005","unstructured":"Li J, Ji L . Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005; 95: 221\u2013227.","journal-title":"Heredity"},{"key":"BFijo2017126_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/gepi.20310","volume":"32","author":"X Gao","year":"2008","unstructured":"Gao X, Starmer J, Martin ER . A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008; 32: 361\u2013369.","journal-title":"Genet Epidemiol"},{"key":"BFijo2017126_CR28","unstructured":"R Core Team R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2012."},{"key":"BFijo2017126_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E . Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2011; 95: 1073\u20131079. e1011.","journal-title":"Fertil Steril"},{"key":"BFijo2017126_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Fu L, Li R, Wang L-N, Yang Y, Liu N-N, Zhang C-M et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 2012; 10: 153.","journal-title":"BMC Med"},{"key":"BFijo2017126_CR31","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","volume":"407","author":"F Dong","year":"2015","unstructured":"Dong F, Deng D, Chen H, Cheng W, Li Q, Luo R et al. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem 2015; 407: 4683\u20134695.","journal-title":"Anal Bioanal Chem"},{"key":"BFijo2017126_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11306-014-0726-y","volume":"11","author":"Z Haoula","year":"2015","unstructured":"Haoula Z, Ravipati S, Stekel DJ, Ortori CA, Hodgman C, Daykin C et al. Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics 2015; 11: 657\u2013666.","journal-title":"Metabolomics"},{"key":"BFijo2017126_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/2213235X01666131203230512","volume":"1","author":"LD Whigham","year":"2013","unstructured":"Whigham LD, Butz E, Dashti D, Tonelli HM, Johnson LK, Cook ME et al. Metabolic evidence of diminished lipid oxidation in women with polycystic ovary syndrome. Curr Metabol 2013; 1: 269\u2013278.","journal-title":"Curr Metabol"},{"key":"BFijo2017126_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1021\/pr401130w","volume":"13","author":"X Zhao","year":"2014","unstructured":"Zhao X, Xu F, Qi B, Hao S, Li Y, Li Y et al. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography\u2013mass spectrometry. J Proteome Res 2014; 13: 1101\u20131111.","journal-title":"J Proteome Res"},{"key":"BFijo2017126_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/jcem-61-5-946","volume":"61","author":"RA Wild","year":"1985","unstructured":"Wild RA, Painter P, Coulson PB, Carruth KB, Ranney G . Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61: 946\u2013951.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR36","first-page":"3389","volume":"82","author":"M Rajkhowa","year":"1997","unstructured":"Rajkhowa M, Neary R, Kumpatla P, Game F, Jones P, Obhrai M et al. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome 1. J Clin Endocrinol Metab 1997; 82: 3389\u20133394.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","volume":"37","author":"GS Conway","year":"1992","unstructured":"Conway GS, Agrawal R, Betteridge D, Jacobs H . Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37: 119\u2013125.","journal-title":"Clin Endocrinol"},{"key":"BFijo2017126_CR38","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N . Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86: 2453\u20132455.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR39","first-page":"3389","volume":"82","author":"M Rajkhowa","year":"1997","unstructured":"Rajkhowa M, Neary RH, Kumpatla P, Game FL, Jones PW, Obhrai MS et al. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 3389\u20133394.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","volume":"54","author":"IR Pirwany","year":"2001","unstructured":"Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N . Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol 2001; 54: 447\u2013453.","journal-title":"Clin Endocrinol"},{"key":"BFijo2017126_CR41","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2009-2444","volume":"95","author":"N Phelan","year":"2010","unstructured":"Phelan N, O'Connor A, Kyaw-Tun T, Correia N, Boran G, Roche HM et al. Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS. J Clin Endocrinol Metab 2010; 95: 3933\u20133939.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR42","doi-asserted-by":"publisher","first-page":"e1001606","DOI":"10.1371\/journal.pmed.1001606","volume":"11","author":"K Fischer","year":"2014","unstructured":"Fischer K, Kettunen J, W\u00fcrtz P, Haller T, Havulinna AS, Kangas AJ et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med 2014; 11: e1001606.","journal-title":"PLoS Med"},{"key":"BFijo2017126_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.7326\/0003-4819-150-2-200901200-00006","volume":"150","author":"K El Harchaoui","year":"2009","unstructured":"El Harchaoui K, Arsenault BJ, Franssen R, Despr\u00e9s J-P, Hovingh GK, Stroes ESG et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 2009; 150: 84\u201393.","journal-title":"Ann Intern Med"},{"key":"BFijo2017126_CR44","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","volume":"113","author":"JD Otvos","year":"2006","unstructured":"Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by Gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial. Circulation 2006; 113: 1556\u20131563.","journal-title":"Circulation"},{"key":"BFijo2017126_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clnu.2004.08.004","volume":"24","author":"E Esteve","year":"2005","unstructured":"Esteve E, Ricart W, Fern\u00e1ndez-Real JM . Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005; 24: 16\u201331.","journal-title":"Clin Nutr"},{"key":"BFijo2017126_CR46","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CCJ Kelly","year":"2001","unstructured":"Kelly CCJ, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N . Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86: 2453\u20132455.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR47","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1210\/jc.2005-0011","volume":"90","author":"C Meyer","year":"2005","unstructured":"Meyer C, McGrath BP, Teede HJ . Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 2005; 90: 5711\u20135716.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR48","first-page":"2044","volume":"82","author":"JM Elbers","year":"1997","unstructured":"Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ . Long-term testosterone administration increases visceral fat in female to male transsexuals 1. J Clin Endocrinol Metab 1997; 82: 2044\u20132047.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR49","first-page":"265","volume":"79","author":"KH Polderman","year":"1994","unstructured":"Polderman KH, Gooren L, Asscheman H, Bakker A, Heine RJ . Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 1994; 79: 265\u2013271.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR50","first-page":"4420","volume":"83","author":"MP Diamond","year":"1998","unstructured":"Diamond MP, Grainger D, Diamond MC, Sherwin RS, DeFronzo RA . Effects of methyltestosterone on insulin secretion and sensitivity in women 1. J Clin Endocrinol Metab 1998; 83: 4420\u20134425.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR51","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/jc.2005-1666","volume":"91","author":"AD Coviello","year":"2006","unstructured":"Coviello AD, Legro RS, Dunaif A . Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006; 91: 492\u2013497.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR52","doi-asserted-by":"publisher","first-page":"E740","DOI":"10.1152\/ajpendo.00533.2011","volume":"302","author":"X Wang","year":"2012","unstructured":"Wang X, Smith GI, Patterson BW, Reeds DN, Kampelman J, Magkos F et al. Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women. Am J Physiol Endocrinol Metab 2012; 302: E740\u2013E746.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2017126_CR53","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2337\/diabetes.51.6.1949","volume":"51","author":"HM Colhoun","year":"2002","unstructured":"Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH . Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002; 51: 1949\u20131956.","journal-title":"Diabetes"},{"key":"BFijo2017126_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/011542650802300163","volume":"23","author":"GU Liepa","year":"2008","unstructured":"Liepa GU, Sengupta A, Karsies D . Polycystic ovary syndrome (PCOS) and other androgen excess\u2013related conditions: can changes in dietary intake make a difference? Nutr Clin Pract 2008; 23: 63\u201371.","journal-title":"Nutr Clin Pract"},{"key":"BFijo2017126_CR55","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1210\/jc.2016-2586","volume":"101","author":"DA Dumesic","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab 2016; 101: 4178\u20134188.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2017126_CR56","first-page":"E1101","volume":"269","author":"G Tonolo","year":"1995","unstructured":"Tonolo G, Ciccarese M, Brizzi P, Milia S, Dessole S, Puddu L et al. Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women. Am J Physiol 1995; 269: E1101\u2013E1105.","journal-title":"Am J Physiol"},{"key":"BFijo2017126_CR57","doi-asserted-by":"publisher","first-page":"742","DOI":"10.7326\/0003-4819-155-11-201112060-00006","volume":"155","author":"S Mora","year":"2011","unstructured":"Mora S, Buring JE, Ridker PM, Cui Y . Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levelsA Cohort Study. Ann Intern Med 2011; 155: 742\u2013750.","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ijo2017126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2017126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ijo.2017.126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2017126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:43:31Z","timestamp":1719225811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2017126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFijo2017126"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2017.126","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]},"assertion":[{"value":"3 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AJK, PS and MAK are shareholders of Brainshake Ltd., a start-up company offering NMR-based metabolite profiling. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}